Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lingyi Biotech Co., Ltd.

Clinical trials sponsored by Lingyi Biotech Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

One-Time gene therapy could change gaucher treatment forever Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2

One-Time gene therapy could change gaucher treatment forever

Disease control Recruiting now

This study tests a new gene therapy called LY-M001 for adults with Gaucher disease type 1, a genetic disorder that causes organ damage and other health problems. The therapy uses a harmless virus to deliver a working copy of the GBA1 gene to liver cells, aiming to restore the mis…

Phase 1/2 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC